Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.92%
0%
-15.92%
6 Months
3.68%
0%
3.68%
1 Year
21.58%
0%
21.58%
2 Years
28.03%
0%
28.03%
3 Years
-8.15%
0%
-8.15%
4 Years
-50.15%
0%
-50.15%
5 Years
-60.7%
0%
-60.7%
Lee's Pharmaceutical Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.55%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
74.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.44
Tax Ratio
21.23%
Dividend Payout Ratio
28.46%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
26.07%
ROE (avg)
16.32%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.65
EV to EBIT
4.71
EV to EBITDA
4.43
EV to Capital Employed
0.65
EV to Sales
1.06
PEG Ratio
0.66
Dividend Yield
248.62%
ROCE (Latest)
13.72%
ROE (Latest)
14.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'17 - YoY
Dec'17
Dec'16
Change(%)
Net Sales
258.80
231.20
11.94%
Operating Profit (PBDIT) excl Other Income
45.30
72.40
-37.43%
Interest
0.90
1.00
-10.00%
Exceptional Items
-1.60
-0.70
-128.57%
Consolidate Net Profit
47.20
52.70
-10.44%
Operating Profit Margin (Excl OI)
174.90%
313.30%
-13.84%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016
Consolidated Net Profit
YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,400.00
1,053.00
32.95%
Operating Profit (PBDIT) excl Other Income
221.00
109.80
101.28%
Interest
14.20
11.90
19.33%
Exceptional Items
-26.30
-34.90
24.64%
Consolidate Net Profit
68.60
19.90
244.72%
Operating Profit Margin (Excl OI)
52.30%
-37.70%
9.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 32.95% vs -14.61% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 244.72% vs -56.55% in Dec 2023
About Lee's Pharmaceutical Holdings Ltd. 
Lee's Pharmaceutical Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






